Position in JNJ
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$345,830,949
-$119,985,403 QoQ
Shares Held
1,361,700
-28.5% QoQ
Ownership
0.057%
of shares outstanding
% of Portfolio
0.41%
of 13F equity value
Holder Rank
#133
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ACADIAN ASSET MANAGEMENT LLC holds $3,615,172,375 across 15 Drug Manufacturers - General names. JNJ ranks #7 (9.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMY |
Bristol Myers Squibb Co
|
11,593,352 | $668,008,942 | |
| 2 | LLY |
ELI LILLY & Co
|
508,522 | $609,936,593 | |
| 3 | ABBV |
AbbVie Inc.
|
1,901,997 | $478,618,525 | |
| 4 | MRK |
Merck & Co., Inc.
|
3,695,329 | $474,849,776 | |
| 5 | AZN |
Astrazeneca PLC
|
2,262,369 | $428,990,409 | |
| 6 | GSK |
GSK plc
|
6,660,434 | $349,139,950 | |
| 7 | JNJ |
Johnson & Johnson
This page
|
1,361,700 | $345,830,949 | |
| 8 | NVO |
Novo Nordisk A S
|
2,736,697 | $131,197,254 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $345,830,949 | 1,361,700 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $465,816,352 | 1,905,647 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $446,454,269 | 2,157,305 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $475,301,919 | 2,563,380 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $247,023,175 | 1,617,173 | Shares | Defined | 2025-08-07 | |
| 2025-03-31 | $199,078,482 | 1,200,425 | Shares | Defined | 2025-05-21 | |
| 2024-12-31 | $111,070,763 | 768,018 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $127,858,047 | 788,955 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $135,000,684 | 923,650 | Shares | Defined | 2024-08-06 | |
| 2024-03-31 | $113,418,908 | 716,979 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $117,530,235 | 749,842 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $121,319,593 | 778,938 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $149,253,025 | 901,722 | Shares | Defined | 2023-08-07 | |
| 2023-03-31 | $143,106,230 | 923,266 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $181,417,960 | 1,026,991 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $156,245,181 | 956,447 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $163,984,093 | 923,802 | Shares | Defined | 2022-08-09 | |
| 2022-03-31 | $180,312,206 | 1,017,391 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $178,662,086 | 1,044,380 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $191,549,336 | 1,186,064 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $208,577,972 | 1,266,104 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $203,817,337 | 1,240,142 | Shares | Defined | 2021-05-11 | |
| 2020-12-31 | $197,227,042 | 1,253,190 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $174,446,566 | 1,171,726 | Shares | Defined | 2020-11-09 | |
| 2020-06-30 | $209,516,339 | 1,489,841 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $149,664,045 | 1,141,341 | Shares | Defined | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||